Our data are in line with previous studies and with a recent large secondary patient-level analysis of eight randomized clinical trials across different forms of atherosclerotic cardiovascular disease, which observed a strong association between circulating GDF-15 and multiples types of cardiovascular events, including death and hospitalization for heart failure [3]. Here, GDF15 is linked to heart failure.